Download | < Back |
28 Jan 2021 | |
We enclose herewith a copy of Press Release that is being issued by the Company, in connection with receipt of CEP approval for Diclazuril API by the Company.<BR> <BR> You are requested to take the same on record.<BR> | |
View all announcements for SEQUENT SCIENTIFIC LTD. | Source: BSE India |